beta

TXG

10X Genomics, Inc.

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

10X Genomics, Inc. is a life science technology company, which engages in building products to interrogate, understand and master biology. Its integrated solutions include single cell transcriptomics, single cell genomics, single cell epigenomes, linked-reads genomics and spatial transcriptomics. The company's products include Single Cell Gene Expression, Immune Profiling, CNV, ATAC, and Genome and Exome. 10X Genomics was founded by Serge Saxonov, Ben Hindson, Kevin D. Ness and Eduard Diviu Terradas on July 2, 2012 and is headquartered in Pleasanton, CA.

Market Cap: 5.67 Billion

Primary Exchange: NASDAQ

Website: http://www.10xgenomics.com

Shares Outstanding: 21.3 Million

Float: 12.5 Million

Dividend: (%)

Beta: -0.569260138136404

Sector: Health Technology

Industry: Biotechnology

Ethical Flags

Longest drawdown: 45 trading days

From: 2020-01-28 To: 2020-04-03

Lowest Point:

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
Data provided by IEX Cloud